0001780708-19-000003.txt : 20190625 0001780708-19-000003.hdr.sgml : 20190625 20190625141705 ACCESSION NUMBER: 0001780708-19-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190625 DATE AS OF CHANGE: 20190625 EFFECTIVENESS DATE: 20190625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioEclipse Therapeutics, Inc. CENTRAL INDEX KEY: 0001780708 IRS NUMBER: 320304849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-342724 FILM NUMBER: 19918126 BUSINESS ADDRESS: STREET 1: 329 OYSTER POINT BLVD., 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 408.809.1030 MAIL ADDRESS: STREET 1: 329 OYSTER POINT BLVD., 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001780708 BioEclipse Therapeutics, Inc. 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA CALIFORNIA 94080 408.809.1030 DELAWARE ConcentRx, Inc. None Corporation true Pamela Contag 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Director Benjamin Carter 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Stephen Thau 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Catherine Sohn 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Gregory Schiffman 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Biao He 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Mark Frohlich 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Elona Baum 329 Oyster Point Blvd., 3rd Floor 94080 South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2019-06-07 false true true false 0 Venture.co Brokerage Services LLC 173924 None None 171 Battery Street, 1st Floor Burlington VT VERMONT 05401 All States false 9090310 7768257 1322053 false 10 0 131810 0 false BioEclipse Therapeutics, Inc. /s/ Pamela Contag Pamela Contag Chief Executive Officer 2019-06-25